Hiroko Masuda - Concepedia

Author

Hiroko Masuda

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

H Masuda, H. Masuda, HIROKO MASUDA, Hiroko MASUDA, Hiroko Masuda, Masuda, H.

155

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Showa University Gunma University Kyoto University Konan University

About

Hiroko Masuda is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	1.2K
2	Health Sciences	3	3	295
3	Natural Sciences	3	3	103
4	Engineering	2	2	73
5	Public Health	1	1	18

Hiroko Masuda

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes Hiroko Masuda, Keith Baggerly, Ying Wang, Clinical Cancer Research	2013	700
Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. Hiroko Masuda, M Fukumoto, Kazunori Hirayoshi, Journal of Clinical Investigation Collagen FibrilsImmunologyPathologyCell ProliferationHsp47 Mrna	1994	220
Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets Steven Van Laere, Naoto T. Ueno, Pascal Finetti, Clinical Cancer Research	2013	177
Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate‐specific antigen Hisamitsu Ide, Shino Tokiwa, Kentaro Sakamaki, The Prostate	2010	176
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes Hiroko Masuda, Takae Brewer, D.D. Liu, Annals of Oncology Hormonal Receptor-Breast OncologyMedicineHer2-defined SubtypesImmunology	2013	137
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival François Bertucci, Naoto T. Ueno, Pascal Finetti, Annals of Oncology Breast OncologyMedicineImmunologyInflammatory Breast CancerCancer Genomics	2013	127
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis Tamer M. Fouad, Takahiro Kogawa, Diane D. Liu, Breast Cancer Research and Treatment Surgical OncologyOverall Survival DifferencesBreast OncologyDistant MetastasisMedicine	2015	94
Statin use in primary inflammatory breast cancer: a cohort study Takae Brewer, Hiroko Masuda, D.D. Liu, British Journal of Cancer	2013	92
Simvastatin Radiosensitizes Differentiated and Stem-Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation Lara Lacerda, Jay P. Reddy, Diane Liu, Stem Cells Translational Medicine	2014	80
Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients Hiroko Masuda, Norikazu Masuda, Yoshinori Kodama, Cancer Chemotherapy and Pharmacology Surgical OncologyOncologyBreast OncologyPredictive FactorsPathology	2010	75

Page 1